The developing landscape of medication therapy demands a re-evaluation of established approaches. Modern research is shifting focus towards personalized treatment regimens, combining genomics, proteomics, and other advanced biomarkers to anticipate patient response and minimize adverse effects. This emerging paradigm emphasizes targeted interventio